Viewing Study NCT06389409



Ignite Creation Date: 2024-05-06 @ 8:26 PM
Last Modification Date: 2025-12-17 @ 3:05 AM
Study NCT ID: NCT06389409
Status: None
Last Update Posted: 2024-04-29 00:00:00
First Post: 2024-02-20 00:00:00

Brief Title: Study on the Quality of Life and Functional/Oncological Outcome of Testicular Cancer Patients
Sponsor: IRCCS San Raffaele
Organization: IRCCS San Raffaele

Study Overview

Official Title: Observational Study on the Quality of Life and Functional/Oncological Outcome of Patients Undergoing Surgery for Testicular Removal and/or Removal of Retro-peritoneal Lymph Nodes
Status: None
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Testicular cancer constitutes 1% to 1.5% of male tumors, 5% of urological tumors. In the Western society to which we belong, the incidence is between 3 and 6 new cases per 100,000 inhabitants per year. In particular, this incidence has recorded continuous growth over the last thirty years. Different histologies of this disease are known, with a clear prevalence of germ cell tumors (90-95%).

From these general epidemiological coordinates it can be deduced that this pathology could affects a young segment of the population; It must be underlined that a pathology is peculiar due to the impact it has on the affected individual, who must be treated not only from an oncological point of view but also with regards to the sexual, reproductive and psychological-relational aspects. Such complexity requires a systematic and detailed approach to examine all aspects.

The creation of this database let to have a follow up above all an extension over time that is not present in the literature, especially towards the functional aspects of this condition.

The database will represent a resource for future research.
Detailed Description: Testicular cancer constitutes 1 to 15 of male tumors 5 of urological tumors In the Western society to which we belong the incidence is between 3 and 6 new cases per 100000 inhabitants per year In particular this incidence has recorded continuous growth over the last thirty years Different histologies of this disease are known with a clear prevalence of germ cell tumors 90-95

From these general epidemiological coordinates it can be deduced that this pathology could affects a young segment of the population It must be underlined that a pathology is peculiar due to the impact it has on the affected individual who must be treated not only from an oncological point of view but also with regards to the sexual reproductive and psychological-relational aspects Such complexity requires a systematic and detailed approach to examine all aspects

The creation of this database let to have a follow up above all an extension over time that is not present in the literature especially towards the functional aspects of this condition

The database will represent a resource for future research

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None